Biosimilars Market Prediction Up 20 Percent from 2012

Source: PharmaManufacturing.com

May 08, 2013

Drug Store News

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study by British market research firm Visiongain. They forecast the $2.445 billion market size marked more than 20% of growth from 2012 and would account for about 2% of the overall market for biologics. The market is expected to grow rapidly through 2023 as biosimilars hit the market in the United States and European Union. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments